GET A QUOTE

Osteopontin N-Half ELISA Kit

  • Created on the 1 February, 2017.

BACKGROUND

Osteopontin (OPN) is a highly acidic calcium binding glycosylated phosphoprotein, also a secretory glycoprotein that was first isolated from the bone. It has a molecular weight which can vary as a result of phosphorylation and sugar chain formation, in general it can be anything from 44 to 66kDa. Osteopontin has a unique characteristic in that it can assume a number of different molecular forms in vivo as a result of phosphorylation, RNA splicing, degradation by protease, saccharification, sulfation and glycosylation. It also contains an Arg-Gly-Asp (RGD) amino acid sequence, this motif allows OPN to bind members of the integrin family (such as avb3) of cell surface receptors.

OPN is known to be able to coexist with thrombin locally in tissues that are inflamed, injured, vascularized and tumors. This ability to coexist with thrombin can help to increase the likelihood of proteolysis and there is growing evidence that this may have a vital physiological role. This ELISA kit is specifically designed for measuring the N-terminal OPN (OPN N-Half) fragment cleaved by thrombin. Therefore, any other OPN molecules that are not cleaved by thrombin will not be detected by this assay.

INTENDED USE

Osteopontin N-half ELISA kit is a reliable quantitative method for measuring osteopontin N-terminal (OPN N-Half) in human EDTA plasma, cell culture media, urine and synovial fluid. This assay has a sensitivity detection limit of 3.0 pmol/L.

SENSITIVITY

The minimum sensitivity detection limit of osteopontin N-terminal (OPN N-Half) using this human osteopontin N-half ELISA kit was approximately 3.0 pmol/L. The dynamic assay range for this kit is 6.25 – 400 pmol/L.

REFERENCES

  1. Molecular cloning and sequencing of cDNA encoding urinary stone protein, which is identical to osteopontin. Biochem. Biophys. Res. Commun. (1992) 184: 859-864. Kohri, K., et al.
  2. Phosphate is a specific signal for induction of osteopontin gene expression. Proc. Nat. Acad. Sci. (2000) 97: 8352-8357. Beck, G. R., Jr.; Zerler, B.; Moran, E.
  3. Osteopontin as a potential diagnostic biomarker for ovarian cancer. JAMA (2002) 287 (13): 1671-1679. Kim J-H., et al.
  4. Enhanced local production of osteopontin in rheumatoid joints. J Rheumatol. (2002) 29 (10): 2061-2067. Ohshima S., et al.

ADDITIONAL INFORMATION

  • Full Name: Osteopontin N-Half ELISA Kit
  • Reactivity: Human
  • Sample Type: EDTA Plasma, Cell Culture Media, Synovial Fluid, Urine
  • Sensitivity:  3.0 pmol/L

OTHER RELATED ELISA KITS

TESTIMONIALS arrow icon

Your secretory IgA ELISA kit gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA kit performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA kits from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA kits. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford